Leerink Partners Raises Price Target as Nevro's (NVRO) Guide Shows Increased Confidence

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. IRT
7. QCOM
8. ASO
9. LAES
10. NTHI

Go back to Leerink Partners Raises Price Target as Nevro's (NVRO) Guide Shows Increased Confidence

Nevro Reports Fourth Quarter and Full Year 2015 Financial Results

February 29, 2016 4:09 PM EST

REDWOOD CITY, Calif., Feb. 29, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three months and full year ended December 31, 2015.

2015 Accomplishments & Highlights:

Achieved revenue of $69.6 million for the full year 2015, an increase of 114% as reported, over the prior year U.S. revenue of $24.3 million for 2015 International revenue of $45.3 million for 2015, an increase of 62% constant currency and 39% as reported,... More

Nevro Announces Executive Succession

February 29, 2016 4:09 PM EST

REDWOOD CITY, Calif., Feb. 29, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO) Board of Directors announced today that Michael DeMane, Nevro's Chief Executive Officer since March 2011, will transition to the role of Executive Chairman of the Board of Directors effective June 1, 2016.  Also on that date, Rami Elghandour, Nevro's current President, will assume the role of President and Chief Executive Officer.  Mr. DeMane intends to remain actively engaged in the company as Executive Chairman, where he will focus on long-term strategy and industry liaison... More